Contributions of multimodal imaging

av Oyen, Wim JG
I publikationen Cancer Imaging (2014)

Consensus Procedures in Oncological Imaging: The Case of Prostate Cancer

av Fanti, Stefano, Oyen, Wim, Lalumera, Elisabetta
I publikationen Cancers (Basel) (2019)

FIAU: From reporter gene imaging to imaging of bacterial proliferation

av Boerman, Otto C, Laverman, Peter, Oyen, Wim JG
Publicerad 2012

Predictive and prognostic value of FDG-PET

av de Geus-Oei, Lioe-Fee, Oyen, Wim J.G.
Publicerad 2008

Nuclear medicine imaging and therapy of neuroendocrine tumours

av Gotthardt, Martin, Dijkgraaf, Ingrid, Boerman, Otto C, Oyen, Wim J G
Publicerad 2006

Gastroparesis in patients with inactive Crohn's disease: a case series

av Kristinsson, Jón O, Hopman, Wim PM, Oyen, Wim JG, Drenth, Joost PH
Publicerad 2007

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer

av Brom, Maarten, Joosten, Lieke, Oyen, Wim JG, Gotthardt, Martin, Boerman, Otto C
Publicerad 2012

Radiolabelled peptides for oncological diagnosis

av Laverman, Peter, Sosabowski, Jane K., Boerman, Otto C., Oyen, Wim J. G.
Publicerad 2012

Peritoneal Carcinomatosis of Colorectal Origin: Incidence and Current Treatment Strategies

av Koppe, Manuel J., Boerman, Otto C., Oyen, Wim J. G., Bleichrodt, Robert P.
Publicerad 2006

Peritoneal Carcinomatosis of Colorectal Origin: Standard of Care

av Koppe, Manuel J., Boerman, Otto C., Oyen, Wim J. G., Bleichrodt, Robert P.
Publicerad 2006

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET

av Brom, Maarten, Oyen, Wim J. G., Joosten, Lieke, Gotthardt, Martin, Boerman, Otto C.
Publicerad 2010

Radiolabelled GLP-1 analogues for in vivo targeting of insulinomas

av Brom, Maarten, Joosten, Lieke, Oyen, Wim J.G., Gotthardt, Martin, Boerman, Otto C.
I publikationen Contrast Media Mol Imaging (2012)

FDG-PET/CT in a Patient with Poor-Risk Non-Seminoma Testis with Mature Teratoma and Secondary Gliosarcoma: Multimodality Imaging for Guiding Multimodality Treatment

av Quak, Elske, Kovacs, Iringo, Oyen, Wim J. G., van der Graaf, Winette T. A.
I publikationen Nucl Med Mol Imaging (2015)

Methodological considerations in quantification of oncological FDG PET studies

av Vriens, Dennis, Visser, Eric P., de Geus-Oei, Lioe-Fee, Oyen, Wim J. G.
Publicerad 2009

Multi-modality nuclear medicine imaging: artefacts, pitfalls and recommendations

av van Dalen, Jorn A., Vogel, Wouter V., Corstens, Frans H.M., Oyen, Wim J.G.
Publicerad 2007

Can FDG PET predict radiation treatment outcome in head and neck cancer? Results of a prospective study

av Schinagl, Dominic A. X., Span, Paul N., Oyen, Wim J., Kaanders, Johannes H. A. M.
Publicerad 2011

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma

av Gilles, Rozemarie, de Geus-Oei, Lioe-Fee, Mulders, Peter F. A., Oyen, Wim J. G.
Publicerad 2011

EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems

av Kaalep, Andres, Sera, Terez, Oyen, Wim, Krause, Bernd J., Chiti, Arturo, Liu, Yan, Boellaard, Ronald
I publikationen Eur J Nucl Med Mol Imaging (2017)

Radiolabeled antibodies in renal cell carcinoma

av Stillebroer, Alexander B., Oosterwijk, Egbert, Oyen, Wim J.G., Mulders, Peter F.A., Boerman, Otto C.
Publicerad 2007

Antibody therapy in renal cell carcinoma

av Oosterwijk, Egbert, Boerman, Otto C., Oyen, Wim J. C., Old, Lloyd J., Mulders, Peter F. A.
Publicerad 2008